Psilocybin for Opioid Use Disorder (OUD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Bogenschutz, MD
NYU Langone Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Duke City Recovery Toolbox
Albuquerque, New Mexico, United States
Recruiting - University of New Mexico
Albuquerque, New Mexico, United States
Recruiting - Startcare
Brooklyn, New York, United States
Recruiting - Nyu Langone Health
New York, New York, United States
Recruiting - Vip Community Services, Inc
The Bronx, New York, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Dec 2025
- Primary completion
- 28 Feb 2029
- Completion
- 28 Feb 2029
- Last update posted
- 23 Jan 2026
- Registered enrollment
- 480
- Registry id
- NCT06796062
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.